InsidersTradesSigma
Track the Biocon Limited share price and the full management transaction log of the company, a listed equity based in India. Shares are quoted on the IN market, under the supervision of SEBI (PIT + SAST). Operating in the Health Care sector, Biocon Limited has recorded 275 reports. Market capitalisation: €692.6bn. The latest transaction was filed on 4 April 2024 (Pledge). Among the most active insiders: MANEESH H GHILDYAL. The full history is openly available.
275
Insider Decl.
n/a
Thresholds
€28m
136 ops.
Buy Volume
€10m
127 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Biocon Limited Buy (bullish), based on 20 analysts. Average price target: ₹423.70.
10Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 21,020 of 29,064 companies
36.7
score / 100
Value30
Quality43
FCF yld0.1%
Earn yld0.6%
EV/EBITDA25.1x
ROE1.1%
Gross mgn66%
Net mgn2.3%
Debt/EBITDA4.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 4 April 2024
Declarations275 total
61,827 shares@ ₹256.6016.1% of flowEquity SharesSEBI:d33423a0ae50c4940d55377ef2ebf5b3f1994265
7,328 shares@ ₹256.6020.6% of flowEquity SharesSEBI:c78f095209f404792fd65f44b2c74f009929367e
19,998 shares@ ₹264.3449.4% of flowEquity SharesSEBI:c5839accdeefcf11dbce01d25734d202a6bb77f5
11,000 shares@ ₹260.5511.9% of flowEquity SharesSEBI:ed16c3fd0c3b26e381e0866cdacdf32892ac94ed
6,792 shares@ ₹251.65100.0% of flowEquity SharesSEBI:8c02a46ef9e9423c1c87d009b7223b85c370dd1c
1,000 shares@ ₹275.800.7% of flowEquity SharesSEBI:c8faefb6f687fedbbd2bd70e9c52d31f245f90fa
2,000 shares@ ₹270.951.3% of flowEquity SharesSEBI:ed4c1879ec720ca56279261cbcb527ab0623aa97
5,000 shares@ ₹283.003.4% of flowEquity SharesSEBI:7232bad934bf214da087dd015e0eabf8cfedd242
1,000 shares@ ₹277.350.7% of flowEquity SharesSEBI:0f67abf84d1abf1a8100e4c3baa4aec831e28dfe
1,000 shares@ ₹278.550.7% of flowEquity SharesSEBI:8c72120d5d04071253ec5e5e6b5eb2eb855cde30
20,500 shares@ ₹274.55100.0% of flowEquity SharesSEBI:1dc30af5c2b2bda027dd78ecc0f7201ae33dcf8c
2,000 shares@ ₹279.201.3% of flowEquity SharesSEBI:fa3811b1d532f786d15662e39554072f8dbca8cc
1,000 shares@ ₹277.500.7% of flowEquity SharesSEBI:6425d6aa8d074f3e64f9598813600bf3d19563b5
5,000 shares@ ₹272.503.2% of flowEquity SharesSEBI:68ae0f0041478b87778fbe50351ed7a2f775661c
2,000 shares@ ₹270.451.3% of flowEquity SharesSEBI:19d39aa5e7b35b616b3e7dca35b0178811a620e8
3,000 shares@ ₹269.182.0% of flowEquity SharesSEBI:408a5483dc17e22ad22a6f5203faa4780d60d492
1,000 shares@ ₹271.050.7% of flowEquity SharesSEBI:07a977f84876cf829f0ee8fed71af8bcf4a5651c
5,944 shares@ ₹249.599951.3% of flowEquity SharesSEBI:445c651aaa33be3b246ec5f3ae1539cf00efd8d9
4,980 shares@ ₹248.525123.9% of flowEquity SharesSEBI:50c8c5bdda04c372615367c7790c7336db7f49e2
8,007 shares@ ₹248.525100.0% of flowEquity SharesSEBI:b5b7c42d85acb43edb8dcb2f9bc0cb6a4d5a5eba
36,000 shares@ ₹248.52524.5% of flowEquity SharesSEBI:fb9f062186e70566c08ac2b200d406d5d13f026f
2,000 shares@ ₹246.251.2% of flowEquity SharesSEBI:ab85a60903abea137b410ce909048f44ab90ed1c
2,000 shares@ ₹249.681.2% of flowEquity SharesSEBI:2e5c1d16262dd65df0a62a4a844a818c68cc94c9
3,000 shares@ ₹254.751.8% of flowEquity SharesSEBI:ce9fce6fdcfa0c1b3007731ef1b22b0a907ba0dd
5,001 shares@ ₹246.3749100.0% of flowEquity SharesSEBI:899d5dbf88c4de7057755889e35164ec96eb7970
25 of 275 declarations
关于 Biocon Limited
Biocon Limited 是一家印度生物制药公司，专注于药物的研发和制造。该公司专注于肿瘤学、糖尿病和自身免疫疾病领域。